Key facts
| Price (PPV) | 926 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | orlistat |
| Class | Antiobesity preparations |
| ATC code | A08AB01 |
| Manufacturer | BOTTU S.A. |
| Presentation | Boîte de 84 |
| Nature | Médicament |
| Hospital price | 645 MAD |
| Data collected on | 9/8/2026 |
Indications
Xenical est indiqué en association à un régime modérément hypocalorique, dans le traitement de l’obésité (Indice de Masse Corporelle (IMC) supérieur ou égal à 30 kg/m2), ou du surpoids (IMC supérieur ou égal à 28 kg/m2) associé à des facteurs de risques. Le traitement par orlistat doit être arrêté après 12 semaines si les patients n’ont pas perdu au moins 5 % du poids initial mesuré au début du traitement.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Xenical 120 mg (BOTTU S.A.) contains the same active substance as Xenical 120 mg (Orlistat) at the same strength, but in a different pack: Boîte de 42 at 510 MAD, i.e. 12.14 MAD per unit against 11.02 MAD for Xenical 120 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Xenical 120 mg | BOTTU S.A. | Boîte de 42 | 510 MAD | 12.14 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Xenical 120 mg
Xenical 120 mg belongs to the antiobesity preparations therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Xenical 120 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Xenical 120 mg
Answers to common questions from Moroccan patients about this drug.